Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSIP1 | O75475 | 1/20 | 0.47 |
| ▸ | HSD11B1 | P28845 | 5/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | MMP3 | P08254 | 1/20 | 0.40 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
| ▸ | MMP13 | P45452 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5664985 | 0.93 | HTR6 (0.47) | PSIP1HSD11B1KEAP1NFE2L2MAPT | |
| SCHEMBL64436 | 0.81 | ALDH1A1 (0.63) | MAPTALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL619004 | 0.81 | LMNA (0.41) | ALDH1A1KMT2AMMP8MMP13MEN1 | |
| SCHEMBL2587720 | 0.81 | ALDH1A1 (0.44) | MAPTALDH1A1KMT2AMMP1MMP8 | |
| SCHEMBL5859628 | 0.80 | PSIP1 (0.56) | PSIP1HSD11B1KEAP1NFE2L2MAPT | |
| SCHEMBL9425545 | 0.80 | ALDH1A1 (0.50) | MAPTALDH1A1L3MBTL1HDAC3HDAC4 | |
| SCHEMBL28865930 | 0.79 | ALDH1A1 (0.38) | KEAP1NFE2L2ALDH1A1KMT2AMMP1 | |
| SCHEMBL28932041 | 0.79 | ALDH1A1 (0.38) | MAPTALDH1A1KMT2AMMP1MMP3 | |
| SCHEMBL28166558 | 0.79 | ALDH1A1 (0.59) | MAPTALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL82994 | 0.78 | CA1 (0.44) | HSD11B1MAPTALDH1A1MMP1MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 986 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2921499-B1 | METHOD FOR LIQUID-PHASE SYNTHESIS OF NUCLEIC ACIDS | TAKEDA PHARMACEUTICALS CO (JP) | 2020-01-22 | — | — | EP | claimed |
| US-20160075680-A1 | MODIFIED SOLID SUPPORT FOR THE SYNTHESIS OF OLIGONUCLEOTIDES | FUNDACION IMDEA NANOCIENCIA (ES) | 2016-03-17 | — | — | US | claimed |
| EP-2992002-A1 | MODIFIED SOLID SUPPORT FOR THE SYNTHESIS OF OLIGONUCLEOTIDES | Fundación Imdea Nanociencia (ES) | 2016-03-09 | — | — | EP | claimed |
| WO-2014177533-A1 | MODIFIED SOLID SUPPORT FOR THE SYNTHESIS OF OLIGONUCLEOTIDES | FUNDACIÓN IMDEA NANOCIENCIA (ES) | 2014-11-06 | — | — | WO | claimed |
| EP-2799443-A1 | Modified solid support for the synthesis of oligonucleotides | Fundación Imdea Nanociencia (ES) | 2014-11-05 | — | — | EP | claimed |
| EP-1514542-B1 | Medicinal composition comprising Tacrine or Donepezil for improving brain function. | TOYAMA CHEMICAL CO LTD (JP) | 2012-02-22 | — | — | EP | claimed |
| CN-100579957-C | Novel arylamidine derivative or salt thereof | TOYAMA CHEMICAL CO LTD | 2010-01-13 | — | — | CN | claimed |
| CN-100434079-C | Pyrazine nucleotide/pyrazine nucleoside analogue and medical application thereof | FUJIYAMA CHEMICAL IND CO LTD (JP) | 2008-11-19 | — | — | CN | claimed |
| EP-0840741-B1 | PNA-DNA CHIMERAS AND PNA SYNTHONS FOR THEIR PREPARATION | PERSEPTIVE BIOSYSTEMS INC (US) | 2004-04-28 | — | — | EP | claimed |
| JP-2001518054-A | — | — | 2001-10-09 | — | — | JP | claimed |
| EP-0840741-A1 | PNA-DNA CHIMERAS AND PNA SYNTHONS FOR THEIR PREPARATION | PERSEPTIVE BIOSYSTEMS, INC. (US) | 1998-05-13 | — | — | EP | claimed |
| WO-1996040709-A1 | PNA-DNA CHIMERAS AND PNA SYNTHONS FOR THEIR PREPARATION | PERSEPTIVE BIOSYSTEMS, INC. (US) | 1996-12-19 | — | — | WO | claimed |
| EP-0641207-A4 | ENANTIOMERIC CYNEMICIN ANALOGS, PREPARATION AND USE THEREOF. | SCRIPPS RESEARCH INST (US) | 1996-08-14 | — | — | EP | claimed |
| US-5527805-A | DNA-CLEAVING, CYTOTOXIC AND ANTI-TUMOR COMPOUNDS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1996-06-18 | — | — | US | claimed |
| EP-0641207-A1 | ENANTIOMERIC CYNEMICIN ANALOGS, PREPARATION AND USE THEREOF | THE SCRIPPS RESEARCH INSTITUTE (US) | 1995-03-08 | — | — | EP | claimed |
| WO-1993023046-A1 | ENANTIOMERIC CYNEMICIN ANALOGS, PREPARATION AND USE THEREOF | THE SCRIPPS RESEARCH INSTITUTE (US) | 1993-11-25 | — | — | WO | claimed |
| EP-0074763-B1 | A COLOR PHOTOGRAPHIC LIGHT-SENSITIVE MATERIAL | KONICA CORPORATION (JP) | 1986-03-05 | — | — | EP | claimed |
| CN-118284608-A | Compounds as BCL-2 inhibitors | 重庆复创医药研究有限公司 | 2024-07-02 | — | — | CN | disclosed |
| US-4297437-A | WHEREIN THE DEVELOPER IS REPLENISHED | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1981-10-27 | — | — | US | disclosed |
| EP-0029722-A1 | A processing method for silver halide colour photographic material | KONICA CORPORATION (JP) | 1981-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160075680-A1 | MODIFIED SOLID SUPPORT FOR THE SYNTHESIS OF OLIGONUCLEOTIDES | POLR2H, POLRMT, POLR2E | PSIP1 403/4885HSD11B1 4415/4885KEAP1 2500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.